Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index; 6 of the 21 sources its claims cite were checked for support.

Impact of Two Different Reference Measurement Procedures on Apparent System Accuracy of 18 CE-Marked Current-Generation Blood Glucose Monitoring Systems

Open access

Abstract

BACKGROUND: Measurement accuracy has been assessed for many different blood glucose monitoring systems (BGMS) over the years by different study groups. However, the choice of the comparison measurement procedure may impact the apparent level of accuracy found in such studies. MATERIALS AND METHODS: Measurement accuracy of 18 different BGMS was assessed in a setting based on ISO 15197 using two different comparison methods in parallel: a glucose oxidase (GOD)-based and a hexokinase (HK)-based method. Accuracy limits of ISO 15197 were applied, and additional analyses were performed, including bias, linear regression, and mean absolute relative difference (MARD) to assess the impact of possible differences between comparison methods on the apparent level of accuracy. RESULTS: While ≈80% of BGMS met the accuracy criteria of ISO 15197 when compared with the respective manufacturers' reference measurement procedure, only two-thirds did so against both comparison methods. The mean relative bias ranged from -6.6% to +5.7% for the analysis against the GOD-based method and from -11.1% to +1.3% for the analysis against the HK-based method, whereas MARD results ranged from 3.7% to 9.8% and from 2.3% to 10.5%, respectively. Results of regression analysis showed slopes between 0.85 and 1.08 (GOD-based method) and between 0.81 and 1.01 (HK-based method). CONCLUSIONS: The results of this study indicate that there are systematic differences between the reference measurement procedures used for BGMS calibration as well as for system accuracy assessment. Because of the potential impact on therapy of patients with diabetes resulting from these differences, further steps toward harmonization of the measurement procedures' results are important.

Overview

CoChat Summary

TL;DR

In 18 CE-marked current-generation blood glucose monitoring systems, apparent ISO 15197 accuracy depended on whether the comparison measurement procedure was glucose oxidase (GOD)- or hexokinase (HK)-based. The study concludes that systematic differences between reference measurement procedures can affect accuracy assessment and warrant harmonization.

Key findings

  • About 80% of BGMS met ISO 15197 accuracy criteria when compared with the respective manufacturers’ reference measurement procedure, but only two-thirds did so against both comparison methods. Specifically, 14/18 systems fulfilled criterion A versus GOD and 12/18 versus HK.
  • Mean relative bias ranged from −6.6% to +5.7% versus GOD and from −11.1% to +1.3% versus HK; MARD ranged from 3.7% to 9.8% versus GOD and from 2.3% to 10.5% versus HK.
  • Passing-Bablok slopes ranged from 0.85 to 1.08 versus GOD and from 0.81 to 1.01 versus HK. Bias differed by 4.3%–4.5% between methods (except system 7), with HK generally giving higher results than GOD.
  • For two BGMS (about 10%), the choice of comparison procedure influenced whether ISO 15197 accuracy criteria were met. CEG analysis showed 100% of results in clinically acceptable zones A and B independent of comparison method.

Methods

  • Postmarket surveillance study of 18 CE-marked current-generation BGMS, each evaluated with one reagent system lot, conducted November–December 2018 at IDT, Ulm, Germany; 126 subjects were included to obtain 100 evaluable data sets per BGMS as required by ISO 15197.
  • Accuracy was assessed in parallel against two comparison methods: a GOD-based method (YSI 2300 STAT Plus) and an HK-based method (Cobas Integra 400 plus), using capillary plasma samples and duplicate measurements.
  • Analyses included ISO 15197 accuracy limits, consensus error grid, Bland-Altman bias with 95% limits of agreement, Passing-Bablok linear regression, and mean absolute relative difference (MARD).

Limitations

  • The paper states that without a measurement procedure of higher metrological order (e.g., isotope dilution–gas chromatography–mass spectrometry), it cannot be determined whether the systematic difference is due to the HK-based method, the GOD-based method, or both.
  • The paper notes that each BGMS was evaluated with only one reagent system lot, whereas ISO 15197 intends CEG criterion B to be applied to three reagent system lots combined.
  • The paper states that no information about the manufacturers’ reference measurement procedures was available at manuscript submission, and the HK-based method was assigned as primary reference based on literature and investigator experience.
  • Evident from the text: the study was financially supported by unrestricted grants from six BGMS manufacturers/distributors, and several authors report industry ties, although the authors state the funders had no impact on study procedures or BGMS acquisition.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1177/1932296820948873

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

5 Valid · 2 Not valid · 6 Not checked · 49 Own results and interpretations

24 more claims

Create a free account to see all 62 claims and to verify the 5 references still open.

See all claims — free account
  • Probably not a substantial claim. 24
  • It may state two separate claims as one. 13

Create a free account to see these claims.

Citations

Cites

Show all 38 references

Research works printed but not linked: 5

  1. Österreichische Diabetes Gesellschaft, 2012, Wien Klin Wochenschr, 124, 1
  2. Bundesärztekammer, 2014, Deutsches Ärzteblatt, 111, 1583
  3. Passing H, 1983, J Clin Chem Clin Biochem, 21, 709
  4. Freckmann G, 2014, 50th EASD Annual Meeting
  5. Clinical and Laboratory Standards Institute, 2013, POCT12-A3 - Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities

Cited by

See all 12

Metadata

Authors
Freckmann, G., Baumstark, A., Jendrike, N., Mende, J., Schauer, S., Link, M., Pleus, S., & Haug, C.
Affiliations
Universität Ulm (DE)
Corresponding author
Pleus, Stefan
Venue
Journal of Diabetes Science and Technology
Published
2020-08-19
Volume
16
Issue
5
Pages
1076-1088
ISSN
1932-2968 (ISSN-L)
OpenAlex
W3080454770
Cited by
12
References
38
Citations by year
2025: 4 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 2
FWCI
0.90
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Diabetes Science and Technology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • lifescan
  • roche
  • i-SENS GmbH
  • Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm
  • Beurer GmbH
  • AgaMatrix Europe Limited
  • Ascensia Diabetes Care Deutschland GmbH
Topics
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Physical Sciences › Physics and Astronomy › Instrumentation › Scientific Measurement and Uncertainty Evaluation
Keywords
blood glucose monitoring systems, reference measurement procedure, measurement accuracy, ISO 15197, glucose oxidase method, hexokinase method, mean absolute relative difference, relative bias, calibration, diabetes management, method harmonization
MeSH terms
Blood Glucose, Calibration, Diabetes Mellitus, Glucose Oxidase, Humans, Blood Glucose Self-Monitoring, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of Two Different Reference Measurement Procedures on Apparent System Accuracy of 18 CE-Marked Current-Generation Blood Glucose Monitoring Systems. https://app.cochat.ai/papers/10.1177/1932296820948873
The paper
Freckmann, G., Baumstark, A., Jendrike, N., Mende, J., Schauer, S., Link, M., Pleus, S., & Haug, C. (2022). Impact of Two Different Reference Measurement Procedures on Apparent System Accuracy of 18 CE-Marked Current-Generation Blood Glucose Monitoring Systems. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296820948873

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.